- Home
- PLX vs MDV Comparison
PLX vs MDV Comparison
Compare PLX & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- MDV
- Stock Information
- Founded
- PLX 1993
- MDV 2015
- Country
- PLX United States
- MDV United States
- Employees
- PLX N/A
- MDV N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- MDV Transportation Services
- Sector
- PLX Health Care
- MDV Consumer Discretionary
- Exchange
- PLX Nasdaq
- MDV Nasdaq
- Market Cap
- PLX 127.4M
- MDV 147.6M
- IPO Year
- PLX 1998
- MDV 2022
- Fundamental
- Price
- PLX $1.91
- MDV $14.61
- Analyst Decision
- PLX Strong Buy
- MDV
- Analyst Count
- PLX 1
- MDV 0
- Target Price
- PLX $15.00
- MDV N/A
- AVG Volume (30 Days)
- PLX 705.4K
- MDV 29.9K
- Earning Date
- PLX 11-13-2025
- MDV 11-05-2025
- Dividend Yield
- PLX N/A
- MDV 8.01%
- EPS Growth
- PLX N/A
- MDV N/A
- EPS
- PLX 0.08
- MDV N/A
- Revenue
- PLX $61,948,000.00
- MDV $47,273,000.00
- Revenue This Year
- PLX $14.53
- MDV $1.72
- Revenue Next Year
- PLX $75.77
- MDV $3.86
- P/E Ratio
- PLX $24.60
- MDV N/A
- Revenue Growth
- PLX 62.79
- MDV N/A
- 52 Week Low
- PLX $0.99
- MDV $13.62
- 52 Week High
- PLX $3.10
- MDV $18.11
- Technical
- Relative Strength Index (RSI)
- PLX 70.20
- MDV 42.82
- Support Level
- PLX $1.52
- MDV $14.57
- Resistance Level
- PLX $1.69
- MDV $15.40
- Average True Range (ATR)
- PLX 0.08
- MDV 0.30
- MACD
- PLX 0.03
- MDV -0.07
- Stochastic Oscillator
- PLX 91.67
- MDV 3.83
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About MDV Modiv Industrial Inc. Class C
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.